EarningsQ4 2025 Earnings Report

RedHill Biopharma (2RH) Q4 2025 Earnings Report

5 Followers

DE:2RH Q4 2025 EPS Results

Actual EPS―

Consensus EPS―

Beat/Miss―

One Year Ago EPS―

Actual Revenue―

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2025

Date04/27/2026

TimeBefore Open

Conference CallMonday, April 27, 2026

DE:2RH Upcoming Earnings

RedHill Biopharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 18, 2027	2026 (Q4)	- / -	―	―
Sep 30, 2026	2026 (Q2)	- / -0.90	-2.069	56.56% (+1.17)
Apr 27, 2026	2025 (Q4)	- / -	―	―
Sep 05, 2025	2025 (Q2)	- / -2.07	0	―
May 13, 2025	2025 (Q1)	- / -	―	―
Apr 10, 2025	2024 (Q4)	- / -	―	―
Aug 29, 2024	2024 (Q2)	- / 0.00	0.892	―
May 07, 2024	2024 (Q1)	- / -	―	―
Apr 08, 2024	2023 (Q4)	- / -	-0.045	―
Nov 15, 2023	2023 (Q3)	- / 0.04	-2.142	101.67% (+2.18)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed